An invited talk by Dr. Ramesh Sistla, Managing Director, at the Drug discovery hackathon – DDH2020 in August 2020.

In this talk, he presents what the incorporation of a single fluorine did to this class of IRAK4 inhibitors. He covers briefly, the biology, structure-based designs going hand in hand with SAR evolution for both potency and selectivity. He then presents the molecular basis for the selectivity achieved through the single F. The work has been published in ACS Med. Chem. Lett. 2020, 11, 7, 1402–1409